Verdict Medical Devices

Fresenius Medical starts US commercialisation of haemodiafiltration system

Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney replacement therapy, 5008X CAREsystem. The post Fresenius Medical starts US commercialisation of haemodiafiltration system appeared first on Medical Device Network.

Jun 5, 2025 - 12:55
 0
Fresenius Medical starts US commercialisation of haemodiafiltration system
Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney replacement therapy, 5008X CAREsystem.

The post Fresenius Medical starts US commercialisation of haemodiafiltration system appeared first on Medical Device Network.

Read More

Tags:

Previous Article

RadNet acquires See-Mode to bolster AI ultrasound screening for thyroid cancer

Next Article

Blue Jay Gold acquires Skukum Gold Project in Canada from Tincorp Metals

Related Posts

FDA grants breakthrough device status to BiVACOR’s artificial heart

FDA grants breakthrough device status to BiVACOR’s arti...

Jun 2, 2025  0

Johnson & Johnson MedTech introduces ultrasound catheter for cardiac ablation

Johnson & Johnson MedTech introduces ultrasound cathete...

May 22, 2025  0

Finland’s AIATELLA secures funds for AI cardiovascular imaging solutions

Finland’s AIATELLA secures funds for AI cardiovascular ...

Jun 6, 2025  0